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INTRODUCTION  
Inflammatory pseudotumors (IPTs) are rare, benign 
tumors. They have been reported in the lungs(1), 
which is the most common site of occurrence , lymph 
nodes(2), skin(3), central nervous system(4), blad-
der(5), breast(6), salivary glands(7), pancreas(8), 
spleen(9), and liver(10).  IPT of the liver is a rare, 
benign tumor-like lesion initially reported by Pack 
and Baker in 1953(11). Based on imaging findings, 
IPT is sometimes misdiagnosed as a malignant tumor, 
e.g. hepatocellular carcinoma, cholangiocarcinoma or 
metastatic liver tumor(12-14).  Due to their malignant 
appearance on imaging studies, an exploratory lapa-
rotomy or a hepatectomy is often performed(12-14). 
The needle liver biopsy is most useful for diagnos-
ing IPT, as well as other hepatic mass lesions. Some 
cases of IPT of the liver have been associated with 
malignant tumors(15-19). The association of IPT with 
systemic inflammatory disorders has also been estab-
lished and several cases with Crohn’s disease(20), 
chronic hepatitis C(21), acute alcoholic hepatitis(22), 
and ascaris lumbricoides ova(23) have been reported. 
According to previous case reports, there are three 
types of cancers associated with hepatic IPT: gastro-
intestinal tract(18,19,24) biliary tract(15), and those 
which need systemic chemotherapy(16). We describe 
herein a case of hepatic pseudotumor accompanied by 
colon cancer, mimicking multiple liver metastases as 
diagnosed by percutaneous liver biopsy. 
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Hepatic inflammatory pseudotumor (IPT) is a rare non-neoplastic process of unknown etiology, generally 
following a benign inflammatory condition. It is often mistaken as an either primary or metastatic malig-
nancy in imaging studies. We report a 48 year-old female with numerous target lesions (2-4 cm) seen on 
high resolution ultrasound, spiral CT scan, and MRI in all liver lobes compatible with metastasis. Guided 
biopsies of the lesions were performed twice, but the pathologies showed no evidence of malignancy. 
Colonoscopy revealed adenocarcinoma of the colon. This case highlights liver pseudotumor in the differ-
ential diagnosis of hepatic tumoral lesions. 
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CASE REPORT  
A 48 year-old woman referred to the outpatient gas-
troenterology clinic with sudden onset of severe up-
per right quadrant abdominal pain. On physical ex-
amination, the patient was not febrile, pale, or icteric. 
She appeared to be a healthy, well nourished middle 
aged woman. Abdominal examination revealed right 
upper quadrant tenderness and hepatomegaly. The 
liver surface was coarse, nodular and firm but the 
spleen was not palpable. Ultrasonography of the liver 
revealed numerous target lesions (2-4 cm in diam-
eter). Laboratory tests revealed an erythrocyte sedi-
mentation rate (ESR) of 80 mm/h and carcinoembry-
onic antigen (CEA) of 197 ng/ml (normal < 2.5 ng/
ml), but other laboratory results that included hemo-
globin, leukocytes, alanine aminotransferase (ALT), 
aspartate transaminase (AST), alkaline phosphatase, 
prothrombin time (PT), albumin, lactate dehydroge-
nase (LDH), and alpha-fetoprotein were all normal. 
Spiral CT scan revealed multiple hypodense masses 
in the right and left liver lobes on pre-contrast phase 
and rim enhancement on post-contrast arterial phase 
(Figure 1). MRI study of the abdomen displayed mul-
tiple hypointense masses on T1 weighted images and 
target lesions on T2 weighted images (solid lesions 
or abscesses) of the right and left liver lobes, but in-
trahepatic bile ducts were normal. No para-aortic 
lymphadenopathy was seen. All other intra-abdom-
inal organs including spleen, kidneys, and pancreas 
were normal (Figure 2). Ultrasound guided biopsy of 
the liver lesions was performed. Needle biopsy was 
composed of fragments of liver tissue. Infiltration of 
chronic inflammatory cells that included lymphocytes 
and a few plasma cells were evident in the portal ar-
eas. Both small and large droplets of fat were seen in 
a few hepatocytes (Figure 3). In the margin of one 
fragment, fibrosis, spindle cells and mixoid changes 
were observed (Figure 4). There was no evidence of 
malignancy.
Repeat CT guided biopsy confirmed the first patho-
logic findings and a diagnosis of hepatic pseudotumor 
was established. In further workups, upper GI endos-
copy and colonoscopy were performed. Upper GI 
endoscopy was normal, but in the colonoscopy a tu-
moral lesion in the cecum was seen. Multiple biopsies 
were obtained and pathologic examination confirmed 
adenocarcinoma of the colon. In accordance to two 
pathologic reports of liver lesions and colonic adeno-
carcinoma, the diagnosis of hepatic pseudotumor and 
colon cancer was propounded and we recommended 
a hemicolectomy to the patient. She refused surgery, 
therefore she underwent a chemotherapy regimen of 
FOLFOX6 which was administered for six  courses. 
Imaging studies of the liver repeated after three cours-
es of chemotherapy showed a marked decrease in size 
and number of liver lesions on spiral CT scan. After 
completion of chemotherapy, the option of surgery 
was discussed again with the patient and a right hemi-
Figure 1: Abdominal spiral CT scan:
Multiple hypodense hepatic Lesions
Figure 2: Abdominal MRI:
target Lesions of Liver on T2 Weight image
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colectomy was performed.
DISCUSSION  
IPTs are more often seen in the Asian population and 
are three times more common in men than in women. 
The age range is from 9 months to 83 years with an 
average age at presentation of about 40 years. Al-
though asymptomatic cases have been reported, they 
typically present with vague constitutional symptoms 
such as fever, nausea and vomiting, malaise, anorex-
ia, weight loss, and abdominal pain. These nonspe-
cific symptoms make preoperative diagnosis diffi-
cult(10,25,26).
Hepatomegaly with tenderness is often recognized in 
patients with IPT of the liver. Leukocytosis, increased 
ESR, and elevated serum C-reactive protein levels, 
suggestive of the presence of inflammation, are also 
common in laboratory findings (12) Often tumor 
markers, including alpha-fetoprotein and carcinoem-
bryonic antigen, are normal while elevations in CA 
19–9 have been reported(27,28). In imaging studies, 
IPTs usually present as solitary masses(29). 
In our case, the prominent presenting features were 
right upper quadrant  abdominal pain and tender hep-
atomegaly without fever or weight loss. All labora-
tory tests were normal except high ESR (suggestive 
of inflammation) and elevated CEA that has not been 
reported in previous cases of IPT. Normal alkaline 
phosphatase and lactate dehydrogenase in the pres-
ence of multiple hepatic masses were compatible with 
a diagnosis of IPT and against malignancy in our pa-
tient.  
Histopathologically, IPT is a combination of plasma 
cells, macrophages, and fibroblasts with variable 
collagen deposition(17). The cellular composition 
of IPT is varied among cases. Even in the same le-
sion, the cellular composition may change over time. 
Since various histological features can be identified 
in a single lesion, histological criteria have not been 
proven helpful in the clinical management of these 
lesions other than to exclude  malignancy(30). Al-
though pathological findings in the present case could 
not strictly be diagnosed as classic IPT of the liver, 
this mixed histological feature may be a new variation 
of hepatic pseudotumor with mild fibrosis, inflamma-
tion, and steatosis. 
The etiology and pathogenesis of IPT remain unclear. 
Many theories exist, however, including intraparen-
chymal hemorrhage and necrosis, infection, occlusive 
phlebitis of the intrahepatic veins, immune reaction, 
or secondary reaction to an intrahepatic rupture of a 
biliary radical(31). Perhaps the most popular theory 
suggests an infectious source as a cause. Some have 
hypothesized that microorganisms from certain con-
ditions, such as appendicitis, seed the hepatic paren-
chyma through the bloodstream of the portal vein, 
creating an inflammatory reaction with obliterating 
phlebitis and granuloma formation(12 ).
Figure 3: Liver Pathology: 
Lymphocytes and Plasma cell in the portal areas
Figure 4: Liver Pathology: 
fibrosis, spindle cells and mixoid changes in the margin
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IPT is sometimes misdiagnosed as a malignant tu-
mor based on imaging findings. In several cases, IPT 
has been visualized as a hypoattenuating mass with 
a variable degree of hyperattenuation on enhanced 
CT scans, with the higher attenuation corresponding 
to the areas of intense fibrosis(32), and the areas of 
lower attenuation corresponding to the predominantly 
cellular areas. Despite their rarity, IPLs remain clini-
cally important because of their differential diagno-
ses with both benign and malignant hepatic masses. 
Clinical, radiological, and histological data can help 
distinguish among IPLs and other liver diseases. Spe-
cifically, confirmation of the diagnosis can sometimes 
be made with core biopsy(33). Fine needle aspiration 
should be avoided, as the procedure leads to a high 
incidence of misdiagnosis(33).
Despite over 75% of cases undergoing surgical resec-
tion, the optimum treatment method for hepatic IPT 
has not been established. There is no definite medical 
therapy. Spontaneous regression of the inflammatory 
lesions have been reported in several patients who 
have been observed without hepatic resection(34). 
In our patient, significant decrease of pseudotumors 
were seen after three months of chemotherapy with 
a FOLFOX6 regimen. The present case is unique be-
cause this is the first report of IPT with pathological 
findings of steatosis and elevated CEA in a patient 
with underlying colon cancer(24).
Inflammatory liver pseudotumor should be consid-
ered in the differential diagnosis of multiple hepatic 
masses and colon cancer as a rare underlying cause. 
Ultrasound or CT guided biopsy can be helpful for 
diagnosis.
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